BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25798841)

  • 1. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.
    Sleire L; Skeie BS; Netland IA; Førde HE; Dodoo E; Selheim F; Leiss L; Heggdal JI; Pedersen PH; Wang J; Enger PØ
    Oncogene; 2015 Dec; 34(49):5951-9. PubMed ID: 25798841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response.
    Garcia CG; Kahn SA; Geraldo LHM; Romano I; Domith I; Silva DCLE; Dos Santos Assunção F; Ferreira MJ; Portugal CC; de Souza JM; Romão LF; Netto ADP; Lima FRS; Cossenza M
    Mol Neurobiol; 2018 Aug; 55(8):6816-6833. PubMed ID: 29349577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The X
    Zheng Z; Luo G; Shi X; Long Y; Shen W; Li Z; Zhang X
    Cell Oncol (Dordr); 2020 Feb; 43(1):95-106. PubMed ID: 31617161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
    Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y
    Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
    Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Styryl Benzoic Acid Derivative DC10 Potentiates Radiotherapy by Targeting the xCT-Glutathione Axis.
    Sarowar S; Cirillo D; Játiva P; Nilsen MH; Otragane SA; Heggdal J; Selheim F; Ceña V; Bjørsvik HR; Enger PØ
    Front Oncol; 2022; 12():786739. PubMed ID: 35198439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cystine uptake disrupts the growth of primary brain tumors.
    Chung WJ; Lyons SA; Nelson GM; Hamza H; Gladson CL; Gillespie GY; Sontheimer H
    J Neurosci; 2005 Aug; 25(31):7101-10. PubMed ID: 16079392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema.
    Sehm T; Fan Z; Ghoochani A; Rauh M; Engelhorn T; Minakaki G; Dörfler A; Klucken J; Buchfelder M; Eyüpoglu IY; Savaskan N
    Oncotarget; 2016 Jun; 7(24):36021-36033. PubMed ID: 27074570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
    Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
    PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).
    Tsuchihashi K; Okazaki S; Ohmura M; Ishikawa M; Sampetrean O; Onishi N; Wakimoto H; Yoshikawa M; Seishima R; Iwasaki Y; Morikawa T; Abe S; Takao A; Shimizu M; Masuko T; Nagane M; Furnari FB; Akiyama T; Suematsu M; Baba E; Akashi K; Saya H; Nagano O
    Cancer Res; 2016 May; 76(10):2954-63. PubMed ID: 26980765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism.
    Ma MZ; Chen G; Wang P; Lu WH; Zhu CF; Song M; Yang J; Wen S; Xu RH; Hu Y; Huang P
    Cancer Lett; 2015 Nov; 368(1):88-96. PubMed ID: 26254540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines.
    Pham AN; Blower PE; Alvarado O; Ravula R; Gout PW; Huang Y
    J Pharmacol Exp Ther; 2010 Mar; 332(3):949-58. PubMed ID: 20007406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.
    Otsuki Y; Yamasaki J; Suina K; Okazaki S; Koike N; Saya H; Nagano O
    Cancer Sci; 2020 Jan; 111(1):127-136. PubMed ID: 31692172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death.
    Banjac A; Perisic T; Sato H; Seiler A; Bannai S; Weiss N; Kölle P; Tschoep K; Issels RD; Daniel PT; Conrad M; Bornkamm GW
    Oncogene; 2008 Mar; 27(11):1618-28. PubMed ID: 17828297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
    Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma.
    Nagane M; Kanai E; Shibata Y; Shimizu T; Yoshioka C; Maruo T; Yamashita T
    PLoS One; 2018; 13(4):e0195151. PubMed ID: 29649284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of sulfasalazine-induced cytotoxicity in C6 rat glioma cells.
    Ignarro RS; Facchini G; de Melo DR; Pelizzaro-Rocha KJ; Ferreira CV; Castilho RF; Rogerio F
    Neurosci Lett; 2017 Jan; 638():189-195. PubMed ID: 28007652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive oxygen species involved in the glutamate toxicity of C6 glioma cells via xc antiporter system.
    Mawatari K; Yasui Y; Sugitani K; Takadera T; Kato S
    Neuroscience; 1996 Jul; 73(1):201-8. PubMed ID: 8783242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
    Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.